120 related articles for article (PubMed ID: 36848784)
1. Trends and factors associated with outpatient anticoagulant treatment initiation among VTE patients with active cancer.
Dhamane AD; Shah S; Noxon V; Bruette R; Ferri M; Liu X; Jiang J; Luo X
Thromb Res; 2023 Apr; 224():52-59. PubMed ID: 36848784
[TBL] [Abstract][Full Text] [Related]
2. Incremental health care resource utilization and economic burden of venous thromboembolism recurrence from a U.S. payer perspective.
Lin J; Lingohr-Smith M; Kwong WJ
J Manag Care Pharm; 2014 Feb; 20(2):174-86. PubMed ID: 24456319
[TBL] [Abstract][Full Text] [Related]
3. Treatment patterns of venous thromboembolism in a real-world population: the Q-VTE study cohort.
Tagalakis V; Patenaude V; Kahn SR; Suissa S
Thromb Res; 2014 Oct; 134(4):795-802. PubMed ID: 25135794
[TBL] [Abstract][Full Text] [Related]
4. Utilization of parenteral anticoagulants and warfarin: impact on the risk of venous thromboembolism recurrence in the outpatient setting.
Cai J; Preblick R; Zhang Q; Kwong WJ
Am Health Drug Benefits; 2014 Nov; 7(8):444-51. PubMed ID: 25558306
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulant use in patients with cancer associated venous thromboembolism: a retrospective cohort study.
Rahme E; Feugère G; Sirois C; Weicker S; Ramos E
Thromb Res; 2013 Mar; 131(3):210-7. PubMed ID: 23290095
[TBL] [Abstract][Full Text] [Related]
6. The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism.
Douketis JD; Gu CS; Schulman S; Ghirarduzzi A; Pengo V; Prandoni P
Ann Intern Med; 2007 Dec; 147(11):766-74. PubMed ID: 18056660
[TBL] [Abstract][Full Text] [Related]
7. Comparative effectiveness and safety of extended anticoagulant therapy among Medicare beneficiaries with venous thromboembolism.
Park H; Kang HR; Huang PL; Lo-Ciganic WH; DeRemer CE; Wilson D; Dietrich EA
Clin Transl Sci; 2023 Jan; 16(1):128-139. PubMed ID: 36200137
[TBL] [Abstract][Full Text] [Related]
8. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E
Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and treatment patterns of patients with venous thromboembolism (VTE) transitioning from hospital to post-discharge settings.
Burton T; Hlavacek P; Guo JD; Rosenblatt L; Mardekian J; Ferri M; Russ C; Kline JA
Hosp Pract (1995); 2020 Oct; 48(4):196-205. PubMed ID: 32720816
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of US prescription patterns: Are treatment guidelines for cancer-associated venous thromboembolism being followed?
Khorana AA; Yannicelli D; McCrae KR; Milentijevic D; Crivera C; Nelson WW; Schein JR
Thromb Res; 2016 Sep; 145():51-3. PubMed ID: 27485998
[TBL] [Abstract][Full Text] [Related]
11. Treatment of DVT: how long is enough and how do you predict recurrence.
Agnelli G; Becattini C
J Thromb Thrombolysis; 2008 Feb; 25(1):37-44. PubMed ID: 17906973
[TBL] [Abstract][Full Text] [Related]
12. Cohort Study on the Management of Cancer-Associated Venous Thromboembolism Aimed at the Safety of Stopping Anticoagulant Therapy in Patients Cured of Cancer.
van der Hulle T; den Exter PL; van den Hoven P; van der Hoeven JJ; van der Meer FJ; Eikenboom J; Huisman MV; Klok FA
Chest; 2016 May; 149(5):1245-51. PubMed ID: 26836911
[TBL] [Abstract][Full Text] [Related]
13. Duration of anticoagulant therapy and VTE recurrence in patients with cancer.
Khorana AA; McCrae KR; Milentijevic D; Fortier J; Nelson WW; Laliberté F; Crivera C; Lefebvre P; Schein J
Support Care Cancer; 2019 Oct; 27(10):3833-3840. PubMed ID: 30734088
[TBL] [Abstract][Full Text] [Related]
14. Is Adherence to the American College of Chest Physicians Recommended Anticoagulation Treatment Duration Associated With Different Outcomes Among Patients With Venous Thromboembolism?
Spyropoulos AC; Preblick R; Kwong WJ; Lingohr-Smith M; Lin J
Clin Appl Thromb Hemost; 2017 Sep; 23(6):532-541. PubMed ID: 27899520
[TBL] [Abstract][Full Text] [Related]
15. Inpatient Versus Outpatient Acute Venous Thromboembolism Management: Trends and Postacute Healthcare Utilization From 2011 to 2018.
Lutsey PL; Walker RF; MacLehose RF; Norby FL; Evensen LH; Alonso A; Zakai NA
J Am Heart Assoc; 2021 Oct; 10(20):e020428. PubMed ID: 34622678
[TBL] [Abstract][Full Text] [Related]
16. Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy.
Douketis JD; Foster GA; Crowther MA; Prins MH; Ginsberg JS
Arch Intern Med; 2000 Dec 11-25; 160(22):3431-6. PubMed ID: 11112236
[TBL] [Abstract][Full Text] [Related]
17. Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
Marik PE; Cavallazzi R
PLoS One; 2015; 10(11):e0143252. PubMed ID: 26587983
[TBL] [Abstract][Full Text] [Related]
18. Comparative Effectiveness and Safety of Direct-acting Oral Anticoagulants and Warfarin in Patients with Venous Thromboembolism and Active Cancer: An Observational Analysis.
Dawwas GK; Dietrich E; Smith SM; Davis K; Park H
Clin Ther; 2020 Sep; 42(9):e161-e176. PubMed ID: 32768247
[TBL] [Abstract][Full Text] [Related]
19. Outpatient Treatment of Low-risk Pulmonary Embolism in the Era of Direct Oral Anticoagulants: A Systematic Review.
Maughan BC; Frueh L; McDonagh MS; Casciere B; Kline JA
Acad Emerg Med; 2021 Feb; 28(2):226-239. PubMed ID: 32779290
[TBL] [Abstract][Full Text] [Related]
20. Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient population.
Mahan CE; Fisher MD; Mills RM; Fields LE; Stephenson JJ; Fu AC; Spyropoulos AC
Thromb Res; 2013 Nov; 132(5):520-6. PubMed ID: 24080150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
